Skip to main content
Premium Trial:

Request an Annual Quote

Startup Pepric Completes $1.8M Round

NEW YORK (GenomeWeb News) – Belgian startup Pepric announced recently it had completed a €1.4 million ($1.8 million) financing round.

The company, a spinout of Imec, said the money will be used to support the production and commercialization of its first product, a tool for quantitative molecular and cellular detection in tissue, urine, and blood samples. Additionally, the funds will go toward the development of Pepric's core in vivo detection technology.

A significant part of the financing comes from Spin-Off Financing Instrument, created in 2011 and funded by four Flemish Strategic Research Centres — IBBT, Imec, VIB, and VITO. Imec's investment vehicle for spinout companies, FIDIMEC, also invested in the round.

Pepric develops technology for the quantitative molecular detection and imaging of biological processes "evolving slowly over time," it said in a statement. Using nanotechnology and imaging technologies, it is developing systems similar to PET and SPECT scanners.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more